Below are the first 10 and last 10 pages of uncorrected machine-read text (when available) of this chapter, followed by the top 30 algorithmically extracted key phrases from the chapter as a whole.
Intended to provide our own search engines and external engines with highly rich, chapter-representative searchable text on the opening pages of each chapter.
Because it is UNCORRECTED material, please consider the following text as a useful but insufficient proxy for the authoritative book pages.
Do not use for reproduction, copying, pasting, or reading; exclusively for search engines.
OCR for page 199
Appendix A
Agenda for Information-Gathering Meeting, Geneva, December 2005
COMMITTEE ON THE PREVENTION OF HIV INFECTION AMONG INJECTING DRUG USERS IN HIGH-RISK COUNTRIES
December 19–20, 2005
Geneva, Switzerland
December 19, 2005
9:00–9:15 a.m.
Welcome, Introductions, and Opening Statement
Hugh Tilson, M.D., Dr.PH.
Committee Chair
9:15–9:45 a.m.
Charge to the Committee
Peter Piot, M.D., Ph.D.
Executive Director, UNAIDS
Under Secretary-General of the United Nations
9:45–10:15 a.m.
Overview of Addiction
Michael Farrell, MRCPsych
Reader in Addiction Psychiatry, National Addiction Centre,
Institute of Psychiatry, King’s College, London
OCR for page 200
10:15–11:00 a.m.
Epidemiology of HIV/AIDS Among IDUs in High-Risk Countries and the Global Response
Peter Ghys, M.D.
Acting Associate Director, Epidemic Monitoring and Prevention, Department of Policy, Evidence and Partnerships, UNAIDS
Catherine Anita Hankins, M.D., MSc, FRCPC
Associate Director of Policy, Evidence and Partnerships
Chief Scientific Adviser
UNAIDS
11:00–11:15 a.m.
Break
11:15–12:45 p.m.
Evidence Regarding HIV Prevention for IDUs
Overview:
Gerry V. Stimson Ph.D.
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association
Review of needle and syringe exchange programs:
Dr. Alex Wodak FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent’s Hospital, Darlinghurst, Australia
Review of needle and syringe exchange programs:
Kerstin Käll, M.D., Ph.D.
Clinic for Dependency Disorders
University Hospital, Linköping, Sweden
Review of drug treatment strategies:
Michael Farrell, MRCPsych
Reader in Addiction Psychiatry, National Addiction Centre,
Institute of Psychiatry, King’s College, London
12:45–1:45 p.m.
Lunch
OCR for page 201
1:45–3:15 p.m.
Country Perspectives Panel: Asian and Pacific Countries
Zhang Fujie, M.D.
Director, Division of Treatment and Care National Center for AIDS-STD Control and Prevention, Chinese Center for Disease of Control and Prevention
Adeeba Kamarulzaman, MBBS, FRACP
Head, Infectious Diseases Unit
Department of Medicine
University of Malaya Medical Centre, Malaysia
Chris Beyrer, M.D., M.P.H.
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS
International Training and Research Program
Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health (discussing Thailand)
3:15–3:30 p.m.
Break
3:30–5:45 p.m.
Country Perspectives Panel: Former Soviet States, Central, and Eastern European Countries
Saulius Caplinskas, M.D., Ph.D.
Director, Lithuanian AIDS Centre
Assoc. Prof., Mykolas Romeris University
Monica Ciupagea M.D.
Program Officer
International Harm Reduction Development Program
Open Society Institute, Budapest
Oleg Tchestnov, M.D.
Deputy Director of the International Department
Ministry of Health, Russia
OCR for page 202
Ksenia Eroshina, M.P.H., Ph.D.
Head of Monitoring & Evaluation Department
Open Health Institute, Moscow, Russia
Alexey Mazus M.D.
Head of Moscow AIDS Center
Inga Upmace, M.D.
Deputy Director, AIDS Prevention Center, Latvia
Steering Committee member of CEE-HRN
(Central and Eastern Europe Harm Reduction Network)
Lily Hyde
Harm Reduction and IEC Consultant
International HIV/AIDS Alliance in Ukraine
6:30 p.m.
Reception for all meeting participants at the ILO building, hosted by UNAIDS
December 20, 2005
8:30–10:00 a.m.
Lessons Learned: Experiences in the United States, Canada, Australia, and Western European Countries
Don C. Des Jarlais, Ph.D.
Director of Research, Baron Edmond de Rothschild Chemical Institute, Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York
Alex Wodak, FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent’s Hospital, Darlinghurst, Australia
Roel A. Coutinho, M.D., Ph.D.
Director, Centre for Infectious Disease Control
National Institute for Health and the Environment, The Netherlands
OCR for page 203
Gerry V. Stimson Ph.D.
Emeritus Professor, Imperial College London, and
Executive Director, International Harm Reduction Association
10:00–10:15 a.m.
Break
10:15–12:30 p.m.
Illicit Drug Policies and the HIV Epidemic
Andrew Ball, M.B., B.S., FChAM
Senior Strategy and Operations Advisor
Department of HIV/AIDS
World Health Organization
Christian Kroll
Senior Coordinator, HIV/AIDS Unit
Global Coordinator on HIV/AIDS
UNODC
Chris Beyrer, M.D., M.P.H.
Associate Professor, Department of Epidemiology
Director, Johns Hopkins Fogarty AIDS International Training and Research Program Director, Johns Hopkins Center for Public Health & Human Rights
Johns Hopkins Bloomberg School of Public Health
Tomas Hallberg
Director, European Cities against Drugs (ECAD)
Stockholm, Sweden
George Zazulin
St. Petersburg Regional Director, ECAD, Russia
Alex Wodak, FRACP, FChAM
Director, Alcohol and Drug Service
St. Vincent’s Hospital, Darlinghurst, Australia
Raminta Stuikyte
Director, Central and Eastern European Harm Reduction Network
OCR for page 204
12:30–1:30 p.m.
Lunch
1:30–2:30 p.m.
Community Perspectives
Mr. Loon Gangte (not able to attend; sent written remarks)
President, Delhi Network of Positive People, India
Regional Coordinator for South Asia
Collaborative Fund for HIV Treatment Preparedness
Mr. Samuel Nugraha
Partnership and Network Assistant
UNAIDS Secretariat Indonesia
2:30–3:00 p.m.
Methodological Considerations in Evaluating Evidence
Don C. Des Jarlais, Ph.D.
Director of Research, Baron Edmond de Rothschild Chemical Dependency Institute, Beth Israel Medical Center
Professor of Epidemiology, Department of Epidemiology and Population Health, Albert Einstein College of Medicine, New York
3:00–3:30 p.m.
Public Comments
3:30 p.m.
Adjourn
Representative terms from entire chapter:
hiv prevention
